Orofar Junior (Benzoxonium Chloride, Lidocaine Hydrochloride)

Benzoxonium chloride and lidocaine hydrochloride, the active ingredients in Orofar Junior, are an antiseptic and a local anesthetic presented as a topical oral solution for oromucosal use. It provides relief of oral mucosal pain and helps manage sore throat and mouth ulcer discomfort. GNH USA supplies Orofar Junior as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Orofar Junior, containing an antiseptic and local anesthetic, is used for conditions affecting the oral mucosa.

- Oral mucosal pain: provides temporary relief of pain and discomfort. - Sore throat: reduces irritation and soreness in the pharyngeal area. - Mouth ulcers: alleviates pain and offers antiseptic protection to aid healing.

Adverse reactions may occur with any topical oral preparation. Most are mild and reversible.

Common Side Effects: - Mild burning or stinging sensation at the application site. - Transient numbness of the oral mucosa. - Altered taste perception. - Mild irritation or redness of the mucosa. - Localised rash or mild allergic skin reaction.

Serious or Rare Side Effects: - Anaphylactic reaction with swelling of lips, tongue or throat. - Persistent numbness lasting longer than expected. - Severe oral tissue swelling or angioedema. - Difficulty breathing due to airway involvement. - Severe ulceration or necrosis of the oral mucosa.

Use Orofar Junior only as directed and observe the following safety measures.

- Hypersensitivity: avoid if known allergy to benzoxonium chloride or lidocaine. - Application area: limit use to intact oral mucosa; do not apply to open wounds. - Frequency: do not exceed the recommended number of applications per day. - Pediatric use: consult a healthcare professional before use in children. - Concomitant anesthetics: avoid simultaneous use with other topical anesthetics. - Store at ambient temperature: keep in the original container, protect from moisture and direct sunlight.

Drug interactions with Orofar Junior are limited but should be considered.

Major Interactions (Avoid): - Concurrent use with other topical anesthetics may increase risk of systemic lidocaine toxicity. - Use with systemic local anesthetics (e.g., intravenous lidocaine) may potentiate anesthetic effects.

Moderate Interactions (Monitor Closely): - Co‑administration with alcohol‑based mouthwashes may increase burning sensation. - Use with other oral antiseptics could heighten mucosal irritation. - CYP450 inhibitors (e.g., amiodarone) may slow lidocaine metabolism, requiring monitoring.